Prospective Analysis of Changes in Background Parenchymal Enhancement (BPE) and Amount of Fibroglandular Tissue on Breast MRI in Early Stage Breast Cancer Patients on Tamoxifen
Observational
Observational Model: Cohort, Time Perspective: Prospective
To compare the level of BPE on breast MRI
on breast MRI in premenopausal patients with breast cancer before and during 9-12 months on tamoxifen to determine whether tamoxifen results in a significant decrease in BPE and/or amount of fibroglandular tissue
3 years
No
Valencia King, MD
Principal Investigator
Memorial Sloan-Kettering Cancer Center
United States: Institutional Review Board
10-217
NCT01297231
February 2011
February 2014
Name | Location |
---|